Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort

Systemic sclerosis (SSc) is a chronic disease characterized by skin/internal organ fibrosis, vasculopathy and autoimmunity. Chemokine (C-X-C motif) ligand 4 (CXCL4) is an early SSc biomarker that predicts worse disease outcome. We previously reported that CXCL4 is an autoantigen in SSc, and anti-CXC...

Full description

Bibliographic Details
Main Authors: Raffaella Palazzo, Katia Stefanantoni, Marius Cadar, Alessia Butera, Valeria Riccieri, Roberto Lande, Loredana Frasca
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/11/4/77
_version_ 1827642102264102912
author Raffaella Palazzo
Katia Stefanantoni
Marius Cadar
Alessia Butera
Valeria Riccieri
Roberto Lande
Loredana Frasca
author_facet Raffaella Palazzo
Katia Stefanantoni
Marius Cadar
Alessia Butera
Valeria Riccieri
Roberto Lande
Loredana Frasca
author_sort Raffaella Palazzo
collection DOAJ
description Systemic sclerosis (SSc) is a chronic disease characterized by skin/internal organ fibrosis, vasculopathy and autoimmunity. Chemokine (C-X-C motif) ligand 4 (CXCL4) is an early SSc biomarker that predicts worse disease outcome. We previously reported that CXCL4 is an autoantigen in SSc, and anti-CXCL4 antibodies correlated with IFN-I and were more abundant in patients with lung fibrosis. However, it is unclear whether antibodies to CXCL4 in SSc are only directed to CXCL4 or recognize complexes formed by CXCL4 and heparin. Here, by analyzing an SSc cohort, we addressed the occurrence of circulating heparin-dependent VS heparin-independent anti-CXCL4 antibodies and their relationship with a few disease parameters. We found that heparin-dependent, like the heparin-independent antibodies, are higher in SSc as compared to healthy donors; they are detectable in 24% and 30% of the SSc patients, respectively, and appear inversely correlated and mutually exclusive. Like the heparin-independent antibodies, heparin-dependent antibodies correlated with digital ulcers. However, in contrast to heparin-independent antibodies, heparin-dependent antibodies did not correlate with IFN-I, but were largely expressed in patients with pulmonary arterial hypertension. This pilot study indicates that heparin-dependent antibodies are worth studying in larger SSc cohorts to address whether they discriminate SSc sub-groups with different pathological characteristics and outcomes.
first_indexed 2024-03-09T17:23:53Z
format Article
id doaj.art-4a043ee123a249aeaa653ce32d41d084
institution Directory Open Access Journal
issn 2073-4468
language English
last_indexed 2024-03-09T17:23:53Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Antibodies
spelling doaj.art-4a043ee123a249aeaa653ce32d41d0842023-11-24T12:55:43ZengMDPI AGAntibodies2073-44682022-12-011147710.3390/antib11040077Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ CohortRaffaella Palazzo0Katia Stefanantoni1Marius Cadar2Alessia Butera3Valeria Riccieri4Roberto Lande5Loredana Frasca6Istituto Superiore di Sanità, National Center for Drug Research and Evaluation, Viale Regina Elena, 299, 00161 Rome, ItalyDepartment of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, ItalyDepartment of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, ItalyIstituto Superiore di Sanità, National Center for Drug Research and Evaluation, Viale Regina Elena, 299, 00161 Rome, ItalyDepartment of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, ItalyIstituto Superiore di Sanità, National Center for Drug Research and Evaluation, Viale Regina Elena, 299, 00161 Rome, ItalyIstituto Superiore di Sanità, National Center for Drug Research and Evaluation, Viale Regina Elena, 299, 00161 Rome, ItalySystemic sclerosis (SSc) is a chronic disease characterized by skin/internal organ fibrosis, vasculopathy and autoimmunity. Chemokine (C-X-C motif) ligand 4 (CXCL4) is an early SSc biomarker that predicts worse disease outcome. We previously reported that CXCL4 is an autoantigen in SSc, and anti-CXCL4 antibodies correlated with IFN-I and were more abundant in patients with lung fibrosis. However, it is unclear whether antibodies to CXCL4 in SSc are only directed to CXCL4 or recognize complexes formed by CXCL4 and heparin. Here, by analyzing an SSc cohort, we addressed the occurrence of circulating heparin-dependent VS heparin-independent anti-CXCL4 antibodies and their relationship with a few disease parameters. We found that heparin-dependent, like the heparin-independent antibodies, are higher in SSc as compared to healthy donors; they are detectable in 24% and 30% of the SSc patients, respectively, and appear inversely correlated and mutually exclusive. Like the heparin-independent antibodies, heparin-dependent antibodies correlated with digital ulcers. However, in contrast to heparin-independent antibodies, heparin-dependent antibodies did not correlate with IFN-I, but were largely expressed in patients with pulmonary arterial hypertension. This pilot study indicates that heparin-dependent antibodies are worth studying in larger SSc cohorts to address whether they discriminate SSc sub-groups with different pathological characteristics and outcomes.https://www.mdpi.com/2073-4468/11/4/77SScheparin-dependent antibodiesheparin-independent antibodies
spellingShingle Raffaella Palazzo
Katia Stefanantoni
Marius Cadar
Alessia Butera
Valeria Riccieri
Roberto Lande
Loredana Frasca
Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
Antibodies
SSc
heparin-dependent antibodies
heparin-independent antibodies
title Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
title_full Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
title_fullStr Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
title_full_unstemmed Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
title_short Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
title_sort heparin independent and heparin dependent anti cxcl4 antibodies have a reciprocal expression in a systemic sclerosis patients cohort
topic SSc
heparin-dependent antibodies
heparin-independent antibodies
url https://www.mdpi.com/2073-4468/11/4/77
work_keys_str_mv AT raffaellapalazzo heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT katiastefanantoni heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT mariuscadar heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT alessiabutera heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT valeriariccieri heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT robertolande heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort
AT loredanafrasca heparinindependentandheparindependentanticxcl4antibodieshaveareciprocalexpressioninasystemicsclerosispatientscohort